"Drug Eruptions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.
| Descriptor ID |
D003875
|
| MeSH Number(s) |
C17.800.174.600 C20.543.206.380 C25.100.468.380
|
| Concept/Terms |
Drug Eruptions- Drug Eruptions
- Drug Eruption
- Eruption, Drug
- Eruptions, Drug
- Dermatitis Medicamentosa
- Dermatitis, Adverse Drug Reaction
Morbilliform Drug Reaction- Morbilliform Drug Reaction
- Drug Reaction, Morbilliform
- Drug Reactions, Morbilliform
- Morbilliform Drug Reactions
- Reaction, Morbilliform Drug
- Reactions, Morbilliform Drug
- Maculopapular Exanthem
- Exanthem, Maculopapular
- Exanthems, Maculopapular
- Maculopapular Exanthems
- Morbilliform Exanthem
- Exanthem, Morbilliform
- Exanthems, Morbilliform
- Morbilliform Exanthems
- Maculopapular Drug Eruption
- Drug Eruption, Maculopapular
- Drug Eruptions, Maculopapular
- Eruption, Maculopapular Drug
- Eruptions, Maculopapular Drug
- Maculopapular Drug Eruptions
|
Below are MeSH descriptors whose meaning is more general than "Drug Eruptions".
Below are MeSH descriptors whose meaning is more specific than "Drug Eruptions".
This graph shows the total number of publications written about "Drug Eruptions" by people in this website by year, and whether "Drug Eruptions" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 1 | 3 |
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 3 | 0 | 3 |
| 2002 | 4 | 0 | 4 |
| 2003 | 1 | 2 | 3 |
| 2004 | 4 | 1 | 5 |
| 2005 | 2 | 0 | 2 |
| 2006 | 8 | 2 | 10 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 5 | 6 |
| 2009 | 4 | 1 | 5 |
| 2010 | 5 | 1 | 6 |
| 2011 | 6 | 6 | 12 |
| 2012 | 4 | 4 | 8 |
| 2013 | 4 | 4 | 8 |
| 2014 | 5 | 3 | 8 |
| 2015 | 6 | 4 | 10 |
| 2016 | 9 | 3 | 12 |
| 2017 | 7 | 5 | 12 |
| 2018 | 5 | 2 | 7 |
| 2019 | 6 | 2 | 8 |
| 2020 | 7 | 4 | 11 |
| 2021 | 3 | 2 | 5 |
| 2022 | 3 | 0 | 3 |
| 2024 | 1 | 4 | 5 |
Below are the most recent publications written about "Drug Eruptions" by people in Profiles.
-
Fixed drug eruption due to ibuprofen. Cleve Clin J Med. 2024 Oct 01; 91(10):597-598.
-
Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia. N Engl J Med. 2024 Sep 19; 391(11):1015-1027.
-
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways. Clin Cancer Res. 2024 Jul 01; 30(13):2822-2834.
-
Antihypertensive Medications and Eczematous Dermatitis in Older Adults. JAMA Dermatol. 2024 Jul 01; 160(7):710-716.
-
Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer. Support Care Cancer. 2024 May 15; 32(6):354.
-
Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin. Br J Dermatol. 2022 07; 187(1):126-127.
-
Response to: 'Validation of generalized drug-related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes': reply from the authors. Br J Dermatol. 2022 05; 186(5):911.
-
The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications. Clin Rev Allergy Immunol. 2022 Jun; 62(3):548-561.
-
Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole. Clin Rev Allergy Immunol. 2022 Jun; 62(3):463-475.
-
Validation of generalized drug-related rash diagnoses using International Classification of Diseases 9th and 10th Revision codes. Br J Dermatol. 2022 03; 186(3):583-585.